1. Home
  2. HRMY vs CTRI Comparison

HRMY vs CTRI Comparison

Compare HRMY & CTRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • CTRI
  • Stock Information
  • Founded
  • HRMY 2017
  • CTRI 1909
  • Country
  • HRMY United States
  • CTRI United States
  • Employees
  • HRMY N/A
  • CTRI N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • CTRI
  • Sector
  • HRMY Health Care
  • CTRI
  • Exchange
  • HRMY Nasdaq
  • CTRI Nasdaq
  • Market Cap
  • HRMY 2.2B
  • CTRI 1.8B
  • IPO Year
  • HRMY 2020
  • CTRI 2024
  • Fundamental
  • Price
  • HRMY $34.56
  • CTRI $18.64
  • Analyst Decision
  • HRMY Strong Buy
  • CTRI Hold
  • Analyst Count
  • HRMY 8
  • CTRI 7
  • Target Price
  • HRMY $54.38
  • CTRI $18.83
  • AVG Volume (30 Days)
  • HRMY 557.4K
  • CTRI 476.8K
  • Earning Date
  • HRMY 02-25-2025
  • CTRI 02-26-2025
  • Dividend Yield
  • HRMY N/A
  • CTRI N/A
  • EPS Growth
  • HRMY N/A
  • CTRI N/A
  • EPS
  • HRMY 2.11
  • CTRI N/A
  • Revenue
  • HRMY $681,879,000.00
  • CTRI $2,585,466,000.00
  • Revenue This Year
  • HRMY $25.11
  • CTRI N/A
  • Revenue Next Year
  • HRMY $19.19
  • CTRI $4.42
  • P/E Ratio
  • HRMY $16.46
  • CTRI N/A
  • Revenue Growth
  • HRMY 25.83
  • CTRI N/A
  • 52 Week Low
  • HRMY $28.14
  • CTRI $14.47
  • 52 Week High
  • HRMY $41.61
  • CTRI $28.65
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 35.54
  • CTRI N/A
  • Support Level
  • HRMY $37.03
  • CTRI N/A
  • Resistance Level
  • HRMY $39.91
  • CTRI N/A
  • Average True Range (ATR)
  • HRMY 1.34
  • CTRI 0.00
  • MACD
  • HRMY -0.58
  • CTRI 0.00
  • Stochastic Oscillator
  • HRMY 9.86
  • CTRI 0.00

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

About CTRI Centuri Holdings Inc. Common Stock

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings primarily consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. They operate under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.

Share on Social Networks: